NCT06896201Active, not recruiting
Comfortage - AD Prevention Strategies
Comfortage - Integration of Biomarkers, Genetic and Clinical Risk Factors for AD Prevention Strategies
Source: ClinicalTrials.gov · Last updated 3 Sept 2026
Brief summary (registry, in English)
Study is Interventional, cross-sectional, clinical trial without drug and without device
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 200 (estimated)
- First submitted
- 26 Feb 2025
- Start date
- 7 Oct 2025
- Primary completion date
- Mar 2027
- Lead sponsor
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS
- Diseases
- Alzheimer disease
- NCT number
- NCT06896201
What you commit to
- Study type: Interventional
- Planned participants: 200
- From 7 Oct 2025 to the primary completion date, Mar 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Previous or current participation in clinical trials with anti-amyloid agents
Other illness
- Non degenerative and secondary forms of dementia
Age
- Age under 50 or over 85 years
Other
- Non-native Italian speakers
Who the study is looking for
- subjective cognitive decline, defined as self-experienced persistent decline in cognitive capacity in comparison with a previously normal status and unrelated to an acute event; normal performance on standardised cognitive tests adjusted for age, sex, and education; decline cannot be explained by psychiatric or other neurologic disease, medical disorder, medication, or substance use; no functional impact on daily life activities
- mild cognitive decline, defined as persistent decline in cognitive performance (in comparison with a previous status) reported by the subject or by an informed caregiver; or observed by change on longitudinal cognitive testing; cognitive performance below expected range for that individual based on cognitive test performance (adjusted for age, sex, and education); performs daily life activities independently (but cognitive difficulty may result in detectable but minimal functional impact on the more complex activities of daily life, either self-reported or corroborated by a study partner); Clinical Dementia Rating Scale = 0.5
- Ability to sign and understand the informed consent form
Age in the registry: 50 years to 85 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Fondazione Policlinico Universitario Agostino Gemelli IRCCS Coordinator of this site? Confirm its status | Roma | Italy | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.